A strong specificity control is competition with a large excess of unlabelled cognate promoter DNA. It should reduce the shifted labelled complexes, whereas an unrelated or binding-site-mutant competitor should compete much less effectively. This tests sequence-dependent association rather than non-specific probe retention. A probe-only lane identifies the free probe, and an irrelevant isotype-matched antibody controls whether any added antibody produces aggregation or altered mobility. These controls address different uncertainties and should not be treated as interchangeable.

Articles by others on the same topic (0)

There are currently no matching articles.